What is Agilent Technologies Inc.'s earnings per share (EPS)?

Agilent Technologies Inc. (A) reported diluted earnings per share of $4.57 for fiscal year 2025. This represents a 3.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Agilent Technologies Inc. (A) Financials

Trailing 12 months to July 31, 2026

Revenue $7.4B +8.6% YoY

Net Income $1.4B +18.0% YoY

EPS (Diluted) $5.07 +18.7% YoY

Free Cash Flow $1.3B +16.5% YoY

Market Cap $47.7B as of Oct 7, 2026

Price / Sales 6.5x on $7.4B revenue, trailing 12 months to July 31, 2026

Price / Earnings 33.1x on $1.4B net income, trailing 12 months to July 31, 2026

Price / Book 6.5x on $7.4B equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 7, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jul 31, 2026 Reported Sep 1, 2026 Currency USD FYE October

Newest figures come from the 10-Q for Q3 FY2026, filed Sep 1, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the A SEC filings page.

Agilent Technologies Inc. (A) reported $7.4B in revenue over the twelve months to Jul 31, 2026, up 8.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI A FY2025 2026-10-04

FY2025 revenue recovered, but weaker margins and heavier reinvestment meant less cash emerged from each dollar sold.

The FY2025 rebound was not a clean operating acceleration: revenue recovered while operating margin slipped to 21.3%, so added sales did not produce stronger operating profitability. Meanwhile, free cash flow fell 16.1% as capital spending rose 7.7%, indicating that the recovery required more cash investment rather than converting proportionally into cash.

Gross margin narrowed from 54.3% to 52.4% as revenue recovered. Operating margin also slipped from 22.9% to 21.3%, so the sales rebound did not improve profitability per dollar.

Debt-to-equity fell from 0.6x to 0.5x while liabilities barely changed, indicating that the balance-sheet improvement came mainly through a larger equity base. The current ratio declined from 2.1x to 2.0x, so short-term liquidity cushion narrowed even as long-term leverage eased.

Financial Health Signals

Financial Health Score 67/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Agilent Technologies Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Agilent Technologies Inc. has an operating margin of 21.3%, meaning the company retains $21 of operating profit per $100 of revenue. This strong profitability earns a score of 90/100, reflecting efficient cost management and pricing power. This is down from 22.9% the prior year.

Growth

Agilent Technologies Inc.'s revenue grew 6.7% year-over-year to $6.9B, a solid pace of expansion. This earns a growth score of 33/100.

Leverage

Agilent Technologies Inc. has a moderate D/E ratio of 0.45. This balance of debt and equity financing earns a leverage score of 54/100.

Liquidity

Agilent Technologies Inc.'s current ratio of 1.96 indicates adequate short-term liquidity, earning a score of 58/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Agilent Technologies Inc. converts 16.6% of revenue into free cash flow ($1.2B). This strong cash generation earns a score of 85/100.

Returns

Agilent Technologies Inc. earns a strong 19.3% return on equity (ROE), meaning it generates $19 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 84/100. This is down from 21.9% the prior year.

Altman Z-Score Safe

6.07

Agilent Technologies Inc. scores 6.07, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($47.7B) relative to total liabilities ($6.0B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

5/9

Agilent Technologies Inc. passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.20x

For every $1 of reported earnings, Agilent Technologies Inc. generates $1.20 in operating cash flow ($1.6B OCF vs $1.3B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

13.21x

Agilent Technologies Inc. earns $13.21 in operating income for every $1 of interest expense ($1.5B vs $112.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.9B

YoY+8.1%

QoQ+2.3%

5Y CAGR+3.4%

10Y CAGR+6.0%

Agilent Technologies Inc. generated $1.9B in revenue in Q3 2026. This represents an increase of 8.1% from the same quarter a year earlier. Against the prior quarter it is up 2.3%.

EBITDA

$510.0M

YoY+18.1%

QoQ+9.4%

5Y CAGR+4.0%

10Y CAGR+9.5%

Agilent Technologies Inc.'s EBITDA was $510.0M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 18.1% from the same quarter a year earlier. Against the prior quarter it is up 9.4%.

Net Income

$362.0M

YoY+7.7%

QoQ+6.8%

5Y CAGR+6.5%

10Y CAGR+11.3%

Agilent Technologies Inc. reported $362.0M in net income in Q3 2026. This represents an increase of 7.7% from the same quarter a year earlier. Against the prior quarter it is up 6.8%.

EPS (Diluted)

$1.28

YoY+8.5%

QoQ+6.7%

5Y CAGR+8.3%

10Y CAGR+12.9%

Agilent Technologies Inc. earned $1.28 per diluted share (EPS) in Q3 2026. This represents an increase of 8.5% from the same quarter a year earlier. Against the prior quarter it is up 6.7%.

Cash & Balance Sheet

Free Cash Flow

$439.0M

YoY+69.5%

QoQ+118.4%

5Y CAGR+9.4%

10Y CAGR+10.0%

Agilent Technologies Inc. generated $439.0M in free cash flow in Q3 2026, representing cash available after capex. This represents an increase of 69.5% from the same quarter a year earlier. Against the prior quarter it is up 118.4%.

Cash & Debt

$1.8B

YoY+14.5%

QoQ-2.7%

5Y CAGR+4.2%

10Y CAGR-2.2%

Agilent Technologies Inc. held $1.8B in cash against $3.6B in long-term debt as of Q3 2026.

Dividends Per Share

$0.26

YoY+2.8%

QoQ0.0%

5Y CAGR+5.6%

10Y CAGR+8.3%

Agilent Technologies Inc. paid $0.26 per share in dividends in Q3 2026. This represents an increase of 2.8% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

282M

YoY-0.6%

QoQ-0.2%

5Y CAGR-1.4%

10Y CAGR-1.4%

Agilent Technologies Inc. had 282M shares outstanding in Q3 2026. This represents a decrease of 0.6% from the same quarter a year earlier. Against the prior quarter it is down 0.2%.

Margins & Returns

Gross Margin

55.5%

YoY+4.4pp

QoQ+1.5pp

5Y change+1.8pp

10Y change+3.6pp

Agilent Technologies Inc.'s gross margin was 55.5% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 4.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.5 percentage points.

Operating Margin

23.6%

YoY+2.9pp

QoQ+1.9pp

5Y change+2.4pp

10Y change+9.7pp

Agilent Technologies Inc.'s operating margin was 23.6% in Q3 2026, reflecting core business profitability. This is up 2.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.9 percentage points.

Net Margin

19.3%

YoY-0.1pp

QoQ+0.8pp

5Y change+2.6pp

10Y change+7.4pp

Agilent Technologies Inc.'s net profit margin was 19.3% in Q3 2026, showing the share of revenue converted to profit. This is down 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.8 percentage points.

Return on Equity

4.9%

YoY-0.3pp

QoQ+0.2pp

5Y change-0.4pp

10Y change+2.1pp

Agilent Technologies Inc.'s ROE was 4.9% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is down 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.2 percentage points.

Capital Allocation

R&D Spending

$123.0M

YoY+10.8%

QoQ-2.4%

5Y CAGR+1.7%

10Y CAGR+3.6%

Agilent Technologies Inc. invested $123.0M in research and development in Q3 2026. This represents an increase of 10.8% from the same quarter a year earlier. Against the prior quarter it is down 2.4%.

Share Buybacks

$78.0M

YoY-8.2%

QoQ+20.0%

5Y CAGR-7.1%

10Y CAGR-1.8%

Agilent Technologies Inc. spent $78.0M on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 8.2% from the same quarter a year earlier. Against the prior quarter it is up 20.0%.

Capital Expenditures

$80.0M

YoY-22.3%

QoQ+5.3%

5Y CAGR+8.2%

10Y CAGR+12.8%

Agilent Technologies Inc. invested $80.0M in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 22.3% from the same quarter a year earlier. Against the prior quarter it is up 5.3%.

A Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

A quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$7.4B	$6.9B+6.7%	$6.5B-4.7%	$6.8B-0.2%	$6.8B+8.4%	$6.3B+18.4%	$5.3B+3.4%	$5.2B+5.1%	$4.9B+9.9%	$4.5B+6.4%	$4.2B+4.1%	$4.0B-0.2%	$4.0B+4.0%	$3.9B-43.2%	$6.9B+3.7%	$6.6B
Cost of Revenue	$3.4B	$3.3B+11.1%	$3.0B-11.7%	$3.4B+7.7%	$3.1B+7.3%	$2.9B+16.4%	$2.5B+6.1%	$2.4B+5.6%	$2.2B+7.8%	$2.1B+3.4%	$2.0B+0.4%	$2.0B-3.6%	$2.1B+4.3%	$2.0B-38.9%	$3.3B+5.4%	$3.1B
Gross Profit	$4.0B	$3.6B+3.1%	$3.5B+2.0%	$3.5B-6.9%	$3.7B+9.2%	$3.4B+20.1%	$2.8B+1.1%	$2.8B+4.7%	$2.7B+11.7%	$2.4B+9.2%	$2.2B+7.6%	$2.0B+3.3%	$2.0B+3.6%	$1.9B-47.1%	$3.6B+2.1%	$3.5B
R&D Expenses	$485.0M	$455.0M-5.0%	$479.0M-0.4%	$481.0M+3.0%	$467.0M+5.9%	$441.0M-10.9%	$495.0M+22.5%	$404.0M+4.4%	$387.0M+13.5%	$341.0M+3.6%	$329.0M-0.3%	$330.0M-7.8%	$358.0M+6.2%	$337.0M-49.6%	$668.0M+2.9%	$649.0M
SG&A Expenses	$1.8B	$1.7B+9.0%	$1.6B-4.0%	$1.6B-0.2%	$1.6B+1.1%	$1.6B+8.2%	$1.5B+2.5%	$1.5B+5.1%	$1.4B+11.0%	$1.3B-0.2%	$1.3B+5.4%	$1.2B-0.8%	$1.2B+1.3%	$1.2B-34.8%	$1.8B+0.4%	$1.8B
Operating Income	$1.6B	$1.5B-0.6%	$1.5B+10.2%	$1.4B-16.6%	$1.6B+20.1%	$1.3B+59.2%	$846.0M-10.1%	$941.0M+4.1%	$904.0M+12.0%	$807.0M+31.2%	$615.0M+17.8%	$522.0M+24.6%	$419.0M+8.5%	$386.0M-65.5%	$1.1B+4.5%	$1.1B
EBITDA	N/A	$1.8B+1.3%	$1.7B+7.6%	$1.6B-16.2%	$1.9B+16.0%	$1.7B+44.5%	$1.2B-2.1%	$1.2B+5.8%	$1.1B+9.3%	$1.0B+18.4%	$861.0M+11.1%	$775.0M-3.5%	$803.0M+5.9%	$758.0M-46.6%	$1.4B+7.3%	$1.3B
Interest Expense	$106.0M	$112.0M+16.7%	$96.0M+1.1%	$95.0M+13.1%	$84.0M+3.7%	$81.0M+3.8%	$78.0M+5.4%	$74.0M-1.3%	$75.0M-5.1%	$79.0M+9.7%	$72.0M+9.1%	$66.0M-40.0%	$110.0M+2.8%	$107.0M+5.9%	$101.0M+17.4%	$86.0M
Income Tax	$218.0M	$132.0M-43.1%	$232.0M+134.3%	$99.0M-60.4%	$250.0M+66.7%	$150.0M+22.0%	$123.0M+180.9%	-$152.0M-124.1%	$630.0M+429.4%	$119.0M+45.1%	$82.0M+95.2%	$42.0M+1500.0%	-$3.0M-104.4%	$68.0M+161.8%	-$110.0M-650.0%	$20.0M
Net Income	$1.4B	$1.3B+1.1%	$1.3B+4.0%	$1.2B-1.1%	$1.3B+3.6%	$1.2B+68.3%	$719.0M-32.9%	$1.1B+238.9%	$316.0M-53.8%	$684.0M+48.1%	$462.0M+15.2%	$401.0M-27.0%	$549.0M-25.2%	$734.0M-36.3%	$1.2B+13.9%	$1.0B
EPS (Basic)	N/A	$4.59+3.4%	$4.44+5.2%	$4.22+0.7%	$4.19+5.3%	$3.98+70.8%	$2.33-31.7%	$3.41+248.0%	$0.98-53.8%	$2.12+49.3%	$1.42+18.3%	$1.20-27.3%	$1.65-23.3%	$2.15-35.0%	$3.31+13.4%	$2.92
EPS (Diluted)	$5.07	$4.57+3.2%	$4.43+5.7%	$4.19+0.2%	$4.18+6.1%	$3.94+71.3%	$2.30-31.8%	$3.37+247.4%	$0.97-53.8%	$2.10+50.0%	$1.40+16.7%	$1.20-25.9%	$1.62-23.9%	$2.13-34.9%	$3.27+14.7%	$2.85
Diluted Shares (Avg)	N/A	285M-2.1%	291M-1.7%	296M-1.3%	300M-2.3%	307M-1.6%	312M-1.9%	318M-2.2%	325M-0.3%	326M-0.9%	329M-1.8%	335M-0.9%	338M-2.0%	345M-2.3%	353M-0.6%	355M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Revenue	$1.9B+8.1%	$1.8B+10.0%	$1.8B+7.0%	$1.9B+9.4%	$1.7B+10.1%	$1.7B+6.0%	$1.7B+1.4%	$1.7B+0.8%
Cost of Revenue	$836.0M-1.6%	$845.0M+5.4%	$852.0M+9.0%	$871.0M+11.0%	$850.0M+17.6%	$802.0M+11.9%	$782.0M+4.3%	$785.0M+1.6%
Gross Profit	$1.0B+17.3%	$990.0M+14.3%	$946.0M+5.2%	$990.0M+8.1%	$888.0M+3.9%	$866.0M+1.2%	$899.0M-1.0%	$916.0M+0.1%
R&D Expenses	$123.0M+10.8%	$126.0M+12.5%	$117.0M+3.5%	$119.0M+7.2%	$111.0M-12.6%	$112.0M-0.9%	$113.0M-11.7%	$111.0M-2.6%
SG&A Expenses	$475.0M+13.9%	$465.0M+2.4%	$476.0M+16.1%	$428.0M+7.8%	$417.0M+5.6%	$454.0M+19.5%	$410.0M+3.5%	$397.0M+1.0%
Operating Income	$444.0M+23.3%	$399.0M+33.0%	$353.0M-6.1%	$443.0M+8.6%	$360.0M+8.1%	$300.0M-17.4%	$376.0M-2.1%	$408.0M0.0%
EBITDA	$510.0M+18.1%	$466.0M+24.9%	$420.0M-6.3%	$514.0M+7.8%	$432.0M+9.1%	$373.0M-12.4%	$448.0M+0.4%	$477.0M+1.5%
Interest Expense	$29.0M+3.6%	$25.0M-13.8%	$25.0M-10.7%	$27.0M-15.6%	$28.0M+27.3%	$29.0M+45.0%	$28.0M+27.3%	$32.0M+45.5%
Income Tax	$82.0M+173.3%	$69.0M+53.3%	$59.0M+20.4%	$8.0M-84.0%	$30.0M-50.8%	$45.0M-31.8%	$49.0M-10.9%	$50.0M+190.9%
Net Income	$362.0M+7.7%	$339.0M+57.7%	$305.0M-4.1%	$434.0M+23.6%	$336.0M+19.1%	$215.0M-30.2%	$318.0M-8.6%	$351.0M-26.1%
EPS (Basic)	$1.28+8.5%	$1.20+60.0%	$1.08-3.6%	$1.54+25.2%	$1.18+21.6%	$0.75-28.6%	$1.12-5.9%	$1.23-24.5%
EPS (Diluted)	$1.28+8.5%	$1.20+60.0%	$1.07-3.6%	$1.52+23.6%	$1.18+21.6%	$0.75-28.6%	$1.11-5.9%	$1.23-23.6%
Diluted Shares (Avg)	283M-0.7%	283M-0.7%	284M-1.0%	N/A	285M-2.1%	285M-2.7%	287M-2.4%	N/A

A Balance Sheet

A quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$12.7B+7.4%	$11.8B+10.1%	$10.8B+2.2%	$10.5B-1.6%	$10.7B+11.2%	$9.6B+1.9%	$9.5B+10.7%	$8.5B+1.4%	$8.4B+8.1%	$7.8B+4.2%	$7.5B-30.8%	$10.8B+1.2%	$10.7B+1.4%	$10.5B+16.3%	$9.1B
Current Assets	$4.6B+16.0%	$4.0B-5.4%	$4.2B+10.8%	$3.8B-0.6%	$3.8B+11.2%	$3.4B+7.1%	$3.2B-17.1%	$3.8B-7.7%	$4.2B+14.7%	$3.6B-1.4%	$3.7B-33.1%	$5.5B+10.6%	$5.0B+7.6%	$4.6B-16.9%	$5.6B
Cash & Equivalents	$1.8B+34.6%	$1.3B-16.4%	$1.6B+51.0%	$1.1B-29.0%	$1.5B+3.0%	$1.4B+4.3%	$1.4B-38.5%	$2.2B-16.1%	$2.7B+17.0%	$2.3B+14.3%	$2.0B-9.7%	$2.2B-17.1%	$2.7B+13.8%	$2.4B-33.3%	$3.5B
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0-100.0%	$11.0M	$0
Inventory	$1.0B+5.5%	$972.0M-5.7%	$1.0B-0.7%	$1.0B+25.1%	$830.0M+15.3%	$720.0M+6.0%	$679.0M+6.4%	$638.0M+11.0%	$575.0M+7.9%	$533.0M-1.5%	$541.0M-5.7%	$574.0M-46.2%	$1.1B+5.1%	$1.0B+12.9%	$898.0M
Accounts Receivable	$1.5B+12.3%	$1.3B+2.6%	$1.3B-8.1%	$1.4B+19.9%	$1.2B+12.9%	$1.0B+11.6%	$930.0M+19.8%	$776.0M+7.2%	$724.0M+14.7%	$631.0M+4.1%	$606.0M-3.2%	$626.0M-30.4%	$899.0M-2.6%	$923.0M+7.3%	$860.0M
Long-Term Investments	$133.0M-24.0%	$175.0M+6.7%	$164.0M-15.9%	$195.0M+5.4%	$185.0M+17.1%	$158.0M+54.9%	$102.0M+50.0%	$68.0M-50.7%	$138.0M+2.2%	$135.0M+57.0%	$86.0M+145.7%	$35.0M+40.0%	$25.0M	$0-100.0%	$3.0M
Goodwill	$4.5B-0.1%	$4.5B+13.1%	$4.0B+0.2%	$4.0B-0.6%	$4.0B+10.4%	$3.6B+0.3%	$3.6B+20.9%	$3.0B+14.0%	$2.6B+3.6%	$2.5B+6.4%	$2.4B-5.6%	$2.5B-4.6%	$2.6B-13.1%	$3.0B+93.0%	$1.6B
Total Liabilities	$6.0B+0.6%	$5.9B+20.9%	$4.9B-5.9%	$5.2B-1.7%	$5.3B+11.8%	$4.8B+1.1%	$4.7B+18.5%	$4.0B+10.6%	$3.6B+1.2%	$3.5B+7.2%	$3.3B-40.0%	$5.5B+2.1%	$5.4B+0.9%	$5.4B+12.9%	$4.7B
Current Liabilities	$2.3B+23.9%	$1.9B+18.2%	$1.6B-13.9%	$1.9B+9.0%	$1.7B+16.4%	$1.5B-29.5%	$2.1B+77.6%	$1.2B-7.3%	$1.3B+33.7%	$945.0M-3.2%	$976.0M-42.3%	$1.7B+5.6%	$1.6B-15.4%	$1.9B+3.0%	$1.8B
Non-Current Liabilities	$3.6B-10.2%	$4.1B+22.3%	$3.3B-1.5%	$3.4B-6.7%	$3.6B+9.8%	$3.3B+25.3%	$2.6B-6.3%	$2.8B+20.2%	$2.3B-10.6%	$2.6B+11.6%	$2.3B-38.9%	$3.8B+0.6%	$3.8B+9.7%	$3.5B+19.1%	$2.9B
Long-Term Debt	$3.0B-8.8%	$3.3B+22.3%	$2.7B+0.1%	$2.7B+0.1%	$2.7B+19.5%	$2.3B+27.5%	$1.8B-0.4%	$1.8B-0.1%	$1.8B-5.4%	$1.9B+15.0%	$1.7B-0.5%	$1.7B-38.4%	$2.7B+27.8%	$2.1B+9.3%	$1.9B
Total Equity	$6.7B+14.3%	$5.9B+0.9%	$5.8B+10.2%	$5.3B-1.6%	$5.4B+10.6%	$4.9B+2.6%	$4.7B+4.0%	$4.6B-5.5%	$4.8B+13.9%	$4.2B+1.8%	$4.2B-21.4%	$5.3B+0.3%	$5.3B+2.0%	$5.2B+20.3%	$4.3B
Retained Earnings	$1.4B+85.2%	$750.0M-4.1%	$782.0M+141.4%	$324.0M-6.9%	$348.0M+329.6%	$81.0M+550.0%	-$18.0M+94.6%	-$336.0M-166.7%	-$126.0M-102.1%	$6.1B+9.1%	$5.6B-13.7%	$6.5B+6.5%	$6.1B+10.3%	$5.5B+23.5%	$4.5B

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Total Assets	$14.0B+14.2%	$13.1B+7.5%	$12.8B+7.5%	$12.7B+7.4%	$12.2B+11.2%	$12.2B+12.0%	$11.9B+8.8%	$11.8B+10.1%
Current Assets	$4.7B+10.3%	$4.8B+13.2%	$4.6B+12.4%	$4.6B+16.0%	$4.3B-0.1%	$4.2B+0.1%	$4.1B-5.3%	$4.0B-5.4%
Cash & Equivalents	$1.8B+14.5%	$1.8B+21.6%	$1.8B+19.8%	$1.8B+34.6%	$1.5B-13.7%	$1.5B-11.1%	$1.5B-16.1%	$1.3B-16.4%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$1.1B+10.2%	$1.1B+9.9%	$1.1B+6.2%	$1.0B+5.5%	$1.0B+3.7%	$991.0M-0.9%	$997.0M-3.5%	$972.0M-5.7%
Accounts Receivable	$1.5B+6.9%	$1.5B+9.7%	$1.5B+14.5%	$1.5B+12.3%	$1.4B+12.6%	$1.4B+9.4%	$1.3B+2.5%	$1.3B+2.6%
Long-Term Investments	$130.0M-2.3%	$136.0M+0.7%	$135.0M-22.0%	$133.0M-24.0%	$133.0M-28.5%	$135.0M-23.7%	$173.0M+1.8%	$175.0M+6.7%
Goodwill	$5.0B+12.4%	$4.5B+0.2%	$4.5B+1.2%	$4.5B-0.1%	$4.5B+12.9%	$4.5B+12.9%	$4.4B+11.6%	$4.5B+13.1%
Total Liabilities	$6.6B+12.8%	$5.9B-1.3%	$5.9B+0.3%	$6.0B+0.6%	$5.9B+15.0%	$6.0B+29.7%	$5.9B+23.7%	$5.9B+20.9%
Current Liabilities	$2.3B+21.0%	$2.3B+12.8%	$2.2B+19.5%	$2.3B+23.9%	$1.9B-20.8%	$2.0B+2.8%	$1.9B+15.6%	$1.9B+18.2%
Non-Current Liabilities	$4.3B+8.9%	$3.7B-8.4%	$3.7B-8.6%	$3.6B-10.2%	$4.0B+46.6%	$4.0B+49.4%	$4.0B+27.8%	$4.1B+22.3%
Long-Term Debt	$3.6B+8.8%	$3.1B-8.9%	$3.0B-8.9%	$3.0B-8.8%	$3.4B+56.8%	$3.3B+56.8%	$3.3B+31.0%	$3.3B+22.3%
Total Equity	$7.4B+15.6%	$7.1B+16.1%	$6.9B+14.6%	$6.7B+14.3%	$6.4B+7.9%	$6.1B-1.3%	$6.0B-2.6%	$5.9B+0.9%
Retained Earnings	$1.9B+73.5%	$1.7B+85.5%	$1.5B+62.0%	$1.4B+85.2%	$1.1B+42.6%	$912.0M-16.3%	$916.0M-13.7%	$750.0M-4.1%

A Cash Flow Statement

A quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$1.6B	$1.6B-11.0%	$1.8B-1.2%	$1.8B+35.1%	$1.3B-11.6%	$1.5B+61.2%	$921.0M-9.8%	$1.0B-6.1%	$1.1B+22.3%	$889.0M+12.1%	$793.0M+54.9%	$512.0M-30.0%	$731.0M-36.5%	$1.2B-6.2%	$1.2B-2.5%	$1.3B
Depreciation & Amortization	N/A	$288.0M+12.1%	$257.0M-5.2%	$271.0M-14.5%	$317.0M-1.2%	$321.0M+4.2%	$308.0M+29.4%	$238.0M+13.3%	$210.0M-0.9%	$212.0M-13.8%	$246.0M-2.8%	$253.0M-34.1%	$384.0M+3.2%	$372.0M+23.6%	$301.0M+19.0%	$253.0M
Stock-Based Compensation	N/A	$128.0M-0.8%	$129.0M+16.2%	$111.0M-11.2%	$125.0M+13.6%	$110.0M+32.5%	$83.0M+15.3%	$72.0M+2.9%	$70.0M+16.7%	$60.0M+3.4%	$58.0M+7.4%	$54.0M-43.8%	$96.0M+12.9%	$85.0M+14.9%	$74.0M+2.8%	$72.0M
Capital Expenditures	$342.0M	$407.0M+7.7%	$378.0M+26.8%	$298.0M+2.4%	$291.0M+54.8%	$188.0M+58.0%	$119.0M-23.2%	$155.0M-12.4%	$177.0M+0.6%	$176.0M+26.6%	$139.0M+41.8%	$98.0M-52.2%	$205.0M+5.1%	$195.0M+0.5%	$194.0M+3.2%	$188.0M
Free Cash Flow	$1.3B	$1.2B-16.1%	$1.4B-6.9%	$1.5B+44.4%	$1.0B-21.3%	$1.3B+61.7%	$802.0M-7.4%	$866.0M-4.8%	$910.0M+27.6%	$713.0M+9.0%	$654.0M+58.0%	$414.0M-21.3%	$526.0M-45.0%	$957.0M-7.4%	$1.0B-3.5%	$1.1B
Investing Cash Flow	-$1.3B	-$394.0M+68.7%	-$1.3B-305.8%	-$310.0M+8.3%	-$338.0M+54.9%	-$749.0M-409.5%	-$147.0M+90.8%	-$1.6B-125.5%	-$705.0M-131.9%	-$304.0M-27.7%	-$238.0M+40.5%	-$400.0M-73.9%	-$230.0M+7.3%	-$248.0M+89.5%	-$2.4B-282.8%	$1.3B
Financing Cash Flow	-$95.0M	-$715.0M+4.9%	-$752.0M+19.1%	-$930.0M+32.2%	-$1.4B-97.1%	-$696.0M+2.9%	-$717.0M-139.8%	-$299.0M+62.5%	-$797.0M-294.6%	-$202.0M+24.6%	-$268.0M+75.4%	-$1.1B-830.8%	-$117.0M+78.9%	-$554.0M-1397.3%	-$37.0M+97.8%	-$1.7B
Dividends Paid	$286.0M	$282.0M+2.9%	$274.0M+3.4%	$265.0M+6.0%	$250.0M+5.9%	$236.0M+6.3%	$222.0M+7.8%	$206.0M+7.9%	$191.0M+12.4%	$170.0M+13.3%	$150.0M+12.8%	$133.0M-24.4%	$176.0M+12.8%	$156.0M+50.0%	$104.0M	$0
Share Buybacks	$380.0M	$425.0M-63.0%	$1.1B+100.0%	$575.0M-49.5%	$1.1B+44.5%	$788.0M+68.0%	$469.0M-35.1%	$723.0M+71.3%	$422.0M+117.5%	$194.0M-55.3%	$434.0M+62.5%	$267.0M+33.5%	$200.0M-77.8%	$900.0M+423.3%	$172.0M-65.4%	$497.0M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Operating Cash Flow	$519.0M+43.4%	$277.0M+25.3%	$268.0M-37.8%	$545.0M+13.3%	$362.0M-19.9%	$221.0M-33.6%	$431.0M-11.1%	$481.0M-6.8%
Depreciation & Amortization	$66.0M-8.3%	$67.0M-8.2%	$67.0M-6.9%	$71.0M+2.9%	$72.0M+14.3%	$73.0M+15.9%	$72.0M+16.1%	$69.0M+11.3%
Stock-Based Compensation	$31.0M-3.1%	$34.0M+13.3%	$41.0M+2.5%	N/A	$32.0M+14.3%	$30.0M-6.3%	$40.0M-9.1%	N/A
Capital Expenditures	$80.0M-22.3%	$76.0M-33.3%	$93.0M-4.1%	$93.0M0.0%	$103.0M+12.0%	$114.0M+10.7%	$97.0M+7.8%	$93.0M+10.7%
Free Cash Flow	$439.0M+69.5%	$201.0M+87.9%	$175.0M-47.6%	$452.0M+16.5%	$259.0M-28.1%	$107.0M-53.5%	$334.0M-15.4%	$388.0M-10.2%
Investing Cash Flow	-$1.0B-975.0%	-$77.0M+32.5%	-$93.0M+1.1%	-$90.0M+90.6%	-$96.0M+4.0%	-$114.0M-4.6%	-$94.0M+1.1%	-$954.0M-2285.0%
Financing Cash Flow	$471.0M+315.1%	-$144.0M-24.1%	-$222.0M-23.3%	-$200.0M-900.0%	-$219.0M+11.0%	-$116.0M+60.1%	-$180.0M+25.0%	$25.0M+112.4%
Dividends Paid	$72.0M+1.4%	$72.0M+2.9%	$72.0M+1.4%	$70.0M+2.9%	$71.0M+4.4%	$70.0M+1.4%	$71.0M+2.9%	$68.0M+3.0%
Share Buybacks	$78.0M-8.2%	$65.0M-60.6%	$152.0M+68.9%	$85.0M-74.6%	$85.0M-85.5%	$165.0M-28.3%	$90.0M	$335.0M+318.8%

A Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

A quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	52.4%-1.9pp	54.3%+3.6pp	50.7%-3.6pp	54.4%+0.4pp	53.9%+0.8pp	53.1%-1.2pp	54.3%-0.2pp	54.5%+0.9pp	53.6%+1.4pp	52.3%+1.7pp	50.5%+1.7pp	48.8%-0.2pp	49.0%-3.6pp	52.5%-0.8pp	53.3%
Operating Margin	21.3%-1.6pp	22.9%+3.1pp	19.8%-3.9pp	23.6%+2.3pp	21.3%+5.5pp	15.8%-2.4pp	18.2%-0.2pp	18.4%+0.4pp	18.1%+3.4pp	14.6%+1.7pp	12.9%+2.6pp	10.3%+0.4pp	9.9%-6.4pp	16.3%+0.1pp	16.2%
Net Margin	18.8%-1.1pp	19.8%+1.7pp	18.1%-0.2pp	18.3%-0.8pp	19.1%+5.7pp	13.5%-7.3pp	20.7%+14.3pp	6.4%-8.9pp	15.3%+4.3pp	11.0%+1.1pp	9.9%-3.6pp	13.6%-5.3pp	18.9%+2.0pp	16.8%+1.5pp	15.3%
Return on Equity	19.3%-2.5pp	21.9%+0.6pp	21.2%-2.4pp	23.6%+1.2pp	22.4%+7.7pp	14.8%-7.8pp	22.6%+15.6pp	6.9%-7.2pp	14.2%+3.3pp	10.9%+1.3pp	9.6%-0.7pp	10.4%-3.5pp	13.9%-8.4pp	22.3%-1.2pp	23.5%
Return on Assets	10.2%-0.6pp	10.9%-0.6pp	11.5%-0.4pp	11.9%+0.6pp	11.3%+3.8pp	7.5%-3.9pp	11.3%+7.6pp	3.7%-4.4pp	8.1%+2.2pp	5.9%+0.6pp	5.4%+0.3pp	5.1%-1.8pp	6.9%-4.1pp	10.9%-0.2pp	11.2%
Current Ratio	1.96-0.1x	2.09-0.5x	2.61+0.6x	2.03-0.2x	2.22-0.1x	2.33+0.8x	1.53-1.8x	3.290.0x	3.30-0.5x	3.85+0.1x	3.78+0.5x	3.26+0.1x	3.11+0.7x	2.45-0.6x	3.03
Debt-to-Equity	0.45-0.1x	0.57+0.1x	0.470.0x	0.520.0x	0.510.0x	0.47+0.1x	0.380.0x	0.390.0x	0.37-0.1x	0.45+0.1x	0.40+0.1x	0.31-0.2x	0.51+0.1x	0.410.0x	0.45
Asset Turnover	0.550.0x	0.55-0.1x	0.630.0x	0.65+0.1x	0.590.0x	0.550.0x	0.550.0x	0.580.0x	0.530.0x	0.540.0x	0.54+0.2x	0.370.0x	0.36-0.3x	0.65-0.1x	0.73
FCF Margin	16.6%-4.5pp	21.1%-0.5pp	21.6%+6.7pp	14.9%-5.6pp	20.5%+5.5pp	15.0%-1.7pp	16.8%-1.8pp	18.5%+2.6pp	15.9%+0.4pp	15.6%+5.3pp	10.3%-2.7pp	13.0%-11.6pp	24.6%+9.5pp	15.1%-1.1pp	16.2%

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Gross Margin	55.5%+4.4pp	53.9%+2.0pp	52.6%-0.9pp	53.2%-0.6pp	51.1%-3.1pp	51.9%-2.5pp	53.5%-1.3pp	53.8%-0.4pp
Operating Margin	23.6%+2.9pp	21.7%+3.8pp	19.6%-2.7pp	23.8%-0.2pp	20.7%-0.4pp	18.0%-5.1pp	22.4%-0.8pp	24.0%-0.2pp
Net Margin	19.3%-0.1pp	18.5%+5.6pp	17.0%-2.0pp	23.3%+2.7pp	19.3%+1.5pp	12.9%-6.7pp	18.9%-2.1pp	20.6%-7.5pp
Return on Equity	4.9%-0.3pp	4.8%+1.3pp	4.4%-0.9pp	6.4%+0.5pp	5.3%+0.5pp	3.5%-1.5pp	5.3%-0.3pp	5.9%-2.2pp
Return on Assets	2.6%-0.2pp	2.6%+0.8pp	2.4%-0.3pp	3.4%+0.4pp	2.8%+0.2pp	1.8%-1.1pp	2.7%-0.5pp	3.0%-1.4pp
Current Ratio	2.05-0.2x	2.100.0x	2.07-0.1x	1.96-0.1x	2.25+0.5x	2.09-0.1x	2.20-0.5x	2.09-0.5x
Debt-to-Equity	0.490.0x	0.43-0.1x	0.44-0.1x	0.45-0.1x	0.53+0.2x	0.55+0.2x	0.56+0.1x	0.57+0.1x
Asset Turnover	0.130.0x	0.140.0x	0.140.0x	0.150.0x	0.140.0x	0.140.0x	0.140.0x	0.140.0x
FCF Margin	23.4%+8.5pp	10.9%+4.5pp	9.7%-10.1pp	24.3%+1.5pp	14.9%-7.9pp	6.4%-8.2pp	19.9%-4.0pp	22.8%-2.8pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Agilent Technologies Inc. A	FY2025	$6.9B	$1.3B	18.8%	$47.7B	67/100
IQVIA Holdings Inc. IQV	FY2025	$16.3B	$1.4B	8.3%	$42.5B	50/100
Mettler-Toledo International MTD	FY2025	$4.0B	$869.2M	21.6%	$30.7B	27/100
Idexx Laboratories Inc IDXX	FY2025	$4.3B	$1.1B	24.6%	$39.9B	76/100
Waters Corp WAT	FY2025	$3.2B	$642.6M	20.3%	$42.8B	71/100
Labcorp Holdings Inc. LH	FY2025	$14.0B	$877.0M	6.3%	$25.3B	50/100

Where Agilent Technologies Inc. Ranks

Frequently Asked Questions

What is Agilent Technologies Inc.'s annual revenue?

Agilent Technologies Inc. (A) reported $6.9B in total revenue for fiscal year 2025. This represents a 6.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Agilent Technologies Inc.'s revenue growing?

Agilent Technologies Inc. (A) revenue grew by 6.7% year-over-year, from $6.5B to $6.9B in fiscal year 2025.

Is Agilent Technologies Inc. profitable?

Yes, Agilent Technologies Inc. (A) reported a net income of $1.3B in fiscal year 2025, with a net profit margin of 18.8%.

What is Agilent Technologies Inc.'s EBITDA?

Agilent Technologies Inc. (A) had EBITDA of $1.8B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Agilent Technologies Inc. have?

As of fiscal year 2025, Agilent Technologies Inc. (A) had $1.8B in cash and equivalents against $3.0B in long-term debt.

What is Agilent Technologies Inc.'s gross margin?

Agilent Technologies Inc. (A) had a gross margin of 52.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Agilent Technologies Inc.'s operating margin?

Agilent Technologies Inc. (A) had an operating margin of 21.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Agilent Technologies Inc.'s net profit margin?

Agilent Technologies Inc. (A) had a net profit margin of 18.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Agilent Technologies Inc. pay dividends?

Yes, Agilent Technologies Inc. (A) paid $0.99 per share in dividends during fiscal year 2025.

What is Agilent Technologies Inc.'s return on equity (ROE)?

Agilent Technologies Inc. (A) has a return on equity of 19.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Agilent Technologies Inc.'s free cash flow?

Agilent Technologies Inc. (A) generated $1.2B in free cash flow during fiscal year 2025. This represents a -16.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Agilent Technologies Inc.'s operating cash flow?

Agilent Technologies Inc. (A) generated $1.6B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Agilent Technologies Inc.'s total assets?

Agilent Technologies Inc. (A) had $12.7B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Agilent Technologies Inc.'s capital expenditures?

Agilent Technologies Inc. (A) invested $407.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Agilent Technologies Inc. spend on research and development?

Agilent Technologies Inc. (A) invested $455.0M in research and development during fiscal year 2025.

Does Agilent Technologies Inc. buy back shares?

Yes, Agilent Technologies Inc. (A) spent $425.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Agilent Technologies Inc. have outstanding?

Agilent Technologies Inc. (A) had 283M shares outstanding as of fiscal year 2025.

What is Agilent Technologies Inc.'s current ratio?

Agilent Technologies Inc. (A) had a current ratio of 1.96 as of fiscal year 2025, which is generally considered healthy.

What is Agilent Technologies Inc.'s debt-to-equity ratio?

Agilent Technologies Inc. (A) had a debt-to-equity ratio of 0.45 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Agilent Technologies Inc.'s return on assets (ROA)?

Agilent Technologies Inc. (A) had a return on assets of 10.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Agilent Technologies Inc.'s P/E ratio?

Agilent Technologies Inc. (A) trades at 33.1x earnings, its market capitalization divided by net income of $1.4B net income, trailing 12 months to July 31, 2026. The market capitalization is $47.7B as of Oct 7, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Agilent Technologies Inc.'s price-to-sales ratio?

Agilent Technologies Inc. (A) trades at 6.5x sales, its market capitalization divided by revenue of $7.4B revenue, trailing 12 months to July 31, 2026. The market capitalization is $47.7B as of Oct 7, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Agilent Technologies Inc.'s Altman Z-Score?

Agilent Technologies Inc. (A) has an Altman Z-Score of 6.07, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Agilent Technologies Inc.'s Piotroski F-Score?

Agilent Technologies Inc. (A) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Agilent Technologies Inc.'s earnings high quality?

Agilent Technologies Inc. (A) has an earnings quality ratio of 1.20x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Agilent Technologies Inc. cover its interest payments?

Agilent Technologies Inc. (A) has an interest coverage ratio of 13.21x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Agilent Technologies Inc.?

Agilent Technologies Inc. (A) scores 67 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.